Connection

John O'Bryan to Biological Products

This is a "connection" page, showing publications John O'Bryan has written about Biological Products.
Connection Strength

0.913
  1. Targeting the "undruggable" RAS with biologics. Adv Cancer Res. 2022; 153:237-266.
    View in: PubMed
    Score: 0.718
  2. Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket. Proc Natl Acad Sci U S A. 2022 10 25; 119(43):e2204481119.
    View in: PubMed
    Score: 0.195
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.